Hepatitis Hepatitis 5 billion in 2003, but remained stable as of 2006, which may be attributable to the introduction of effective drug therapies and vaccination campaigns. People infected with chronic hepatitis C tend to be frequent users of the health care system globally.  It has been estimated that a person infected with hepatitis C in the United States will result in a monthly cost of $691.  That number nearly doubles to $1,227 for people with compensated  cirrhosis, while the monthly cost of people with decompensated  cirrhosis is almost five times as large at $3,682.  The wide-ranging effects of hepatitis make it difficult to estimate indirect costs, but studies have speculated that the total cost is $6. 5 billion annually in the United States.  In Canada, 56% of HCV related costs are attributable to cirrhosis and total expenditures related to the virus are expected to peak at CAD$396 million in the year 2032 Hepatitis Hepatitis